Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A patent review of selective CDK9 inhibitors in treating cancer
Tizhi Wu, Xiaowei Wu, Yifan Xu, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 4, pp. 309-322
Closed Access | Times Cited: 9

Showing 9 citing articles:

Design, Synthesis and Biological Evaluation of Novel 9H Purine Derivatives as Potent CDK9 Inhibitors
Chunlei Tang, Dong Wang, Huabing Wang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access | Times Cited: 1
Identification of a Novel Selective CDK9 Inhibitor for the Treatment of CRC: Design, Synthesis, and Biological Activity Evaluation
Ye Zhong, Jing Xu, Ruochen Zhou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4739-4756
Closed Access | Times Cited: 11
The vinyl sulfone motif as a structural unit for novel drug design and discovery
You‐Cai Xiao, Fen‐Er Chen
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 239-251
Closed Access | Times Cited: 11
Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategy
Tizhi Wu, Zhiming Zhang, Guangyue Gong, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115774-115774
Closed Access | Times Cited: 9
Discovery of novel CDK9 inhibitor with tridentate ligand: Design, synthesis and biological evaluation
Ye Zhong, Jing Xu, Shaoyue Ding, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107550-107550
Closed Access | Times Cited: 2
Design, synthesis, molecular modeling and evaluation of 2,4-diaminopyrimidine analogues as promising colorectal cancer drugs
Gopalakrishnan Venkatesan, Chong Yong Ping, Hong Chen, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107854-107854
Closed Access | Times Cited: 1
Discovery of Novel Cdk9 Inhibitor with Tridentate Ligand: Design, Synthesis and Biological Evaluation
Yang Liu, Ye Zhong, Jing Xu, et al.
(2024)
Closed Access
Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development
Yingchun Liu, Zhaobing Xu, Lihong Hu, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 112, pp. 129941-129941
Closed Access
Design and optimization of selective and potent CDK9 inhibitors with flavonoid scaffold for the treatment of acute myeloid leukemia
Tizhi Wu, Bin Yu, Weihong Gong, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115711-115711
Closed Access | Times Cited: 1
Page 1

Scroll to top